← Back to Search
Technology Uptake for Type 1 Diabetes (BEAD-T1D Trial)
Stanford, CA
N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of one year
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to study and improve diabetes care for young people from low-income backgrounds. The research will focus on understanding the barriers and promoters of diabetes management in publicly insured youth and work towards reducing disparities in
See full description
Who is the study for?
This trial is for young people aged 12-21 with Type 1 Diabetes, especially from low socioeconomic backgrounds. Participants must be living with a parent or guardian if under 18 (with their consent) and can give personal consent if over 18.
What is being tested?
The BEAD-T1D study aims to increase the use of diabetes technology among disadvantaged youths. It will explore barriers to care, aiming to improve diabetes management and outcomes in this group.See study design
What are the potential side effects?
Since this intervention focuses on increasing access to diabetes technology rather than a drug or medical procedure, traditional side effects are not applicable. However, there may be psychological or social impacts from participating in the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of one year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Interviews with you on your feedback on the intervention
Survey questions on your feedback on the intervention
Tracking people who complete the study
Secondary study objectives
Changes in diabetes technology usage
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Pilot InterventionExperimental Treatment1 Intervention
The design for this phase is a prospective pilot study. The intervention modules (co-developed with the stakeholder advisory board in Phase 1 of this aim) will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. The investigators will also evaluate youth diabetes management and technology use. Families will be compensated in a stepwise fashion. Virtual delivery of the pilot intervention will facilitate national recruitment and allow for recruitment during the pandemic or any ensuing limitations to in-person recruitment.
Find a Location
Closest Location:Stanford University· Stanford, CA· 1332 miles
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,497 Previous Clinical Trials
4,353,187 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,520 Previous Clinical Trials
17,426,090 Total Patients Enrolled